<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04846751</url>
  </required_header>
  <id_info>
    <org_study_id>PID2020-116159RB-I00</org_study_id>
    <nct_id>NCT04846751</nct_id>
  </id_info>
  <brief_title>Exercise Type That Faster Reduces Postprandial Glycemia.</brief_title>
  <acronym>GLYEXER</acronym>
  <official_title>Exercise Type That Faster Reduces Postprandial Glycemia.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Castilla-La Mancha</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Castilla-La Mancha</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is well established that a bout of 50 min of continuous moderate intensity exercise,&#xD;
      improves insulin sensitivity up to 48 hours after the bout. However, it is less well known,&#xD;
      what is the exercise type more efficient to buffer the elevations in blood glucose elicited&#xD;
      by carbohydrate ingestion. The purpose of this study is to elucidate if intervalic exercise&#xD;
      is superior to continous on improving postprandial glycemic control.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carbohydrate oxidation, glucose and insulin blood concentrations, isotopically measured rate&#xD;
      of appearance of endogenous and exogenous glucose will be measured in 4 ocassions.&#xD;
&#xD;
      Participants will undergo in a cross-over randomized fashion the following trials:&#xD;
&#xD;
        1. Exercise pedalling during 50 min at 60% of their VO2max followed by an oral glucose&#xD;
           tolerance test (OGTT).&#xD;
&#xD;
        2. Exercise pedalling during 50 min in a hot environment (33ÂºC) at 60% of their VO2max&#xD;
           followed by an oral glucose tolerance test (OGTT).&#xD;
&#xD;
        3. Exercise pedalling during 50 min using intervalic bouts averaging 60% of VO2max followed&#xD;
           by an oral glucose tolerance test (OGTT).&#xD;
&#xD;
        4. No exercise, followed by an oral glucose tolerance test (OGTT).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">September 10, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Study composed of 4 trials, full-crossover, administered in a randomized order with the inclusion of a control trial.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood glucose concentration</measure>
    <time_frame>16 weeks</time_frame>
    <description>Incremental area under the curve during the 120 min of the oral glucose tolerance test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood insulin concentration</measure>
    <time_frame>16 weeks</time_frame>
    <description>Incremental area under the curve during the 120 min of the oral glucose tolerance test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carbohydrate oxidation</measure>
    <time_frame>16 weeks</time_frame>
    <description>Measured using indirect calorimetry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Turnover rate of endogenous and exogenous glucose</measure>
    <time_frame>16 weeks</time_frame>
    <description>Measured using isotopic tracers.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">11</enrollment>
  <condition>Glucose, High Blood</condition>
  <condition>Exercise-Induced Hyperinsulinism</condition>
  <arm_group>
    <arm_group_label>AEROBIC EXERCISE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50 min of aerobic exercise by pedaling a cycleergometer at 60% of VO2max</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PLACEBO REST</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No exercise, resting during 50 min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TYPE OF EXERCISE (OR REST)</intervention_name>
    <description>continous exercise in normal temperature, continous exercise in hot environment, intervallic exercise in normal temperature.</description>
    <arm_group_label>AEROBIC EXERCISE</arm_group_label>
    <arm_group_label>PLACEBO REST</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant must be capable and willing to provide consent, understand, instructions&#xD;
             and protocols.&#xD;
&#xD;
          -  Minimal fitness level to be able to complete 50 min of continous exercise at a&#xD;
             moderate intensity.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Any non-controlled medical condition which could influence results or could be&#xD;
             worsened by exercise&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Mora-Rodriguez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Castilla-La Mancha</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Castilla-La Mancha (Exercise Physiology Lab)</name>
      <address>
        <city>Toledo</city>
        <zip>45071</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>April 11, 2021</study_first_submitted>
  <study_first_submitted_qc>April 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Castilla-La Mancha</investigator_affiliation>
    <investigator_full_name>Ricardo Mora</investigator_full_name>
    <investigator_title>Director of the Exercise Lab at Toledo</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperinsulinism</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be shared upon reasonable request.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

